Back to News
Market Impact: 0.25

IWO ETF Factor Report

IWONDAQ
Company FundamentalsAnalyst InsightsTechnology & InnovationHealthcare & Biotech
IWO        ETF Factor Report

Validea's report on the iShares Russell 2000 Growth ETF (IWO) identifies it as a Mid-Cap Momentum ETF with its largest sector exposure in Technology and industry in Biotechnology & Drugs. The ETF exhibits a high momentum score of 64, but notably low scores for quality (9), low volatility (8), and value (23), indicating a portfolio skewed towards high-growth, potentially higher-risk assets with less emphasis on fundamental strength or stability.

Analysis

The iShares Russell 2000 Growth ETF (IWO) presents a highly specific factor exposure profile, as detailed in Validea's fundamental report. The ETF demonstrates a strong tilt towards the momentum factor, with a score of 64, which is consistent with its classification as a Mid-Cap Momentum fund. This is sharply contrasted by its exceptionally low exposure to other strategic factors. The Quality score of 9 and Low Volatility score of 8 indicate that the underlying portfolio is comprised of companies with weaker fundamental underpinnings and higher price volatility. Furthermore, a low Value score of 23 suggests its holdings are trading at significant premiums. The fund's concentration in the Technology sector, and specifically the Biotechnology & Drugs industry, aligns with this profile, capturing companies with high growth potential but also elevated risk and valuation metrics.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

IWO0.00
NDAQ0.00

Key Decisions for Investors

  • Investors seeking tactical exposure to the momentum factor in the mid-cap segment could consider IWO, given its high score of 64 in this specific style.
  • Those with a mandate for capital preservation or a value-oriented approach should be cautious, as the ETF's extremely low scores for Quality (9), Low Volatility (8), and Value (23) are contrary to such strategies.
  • The fund's high-risk profile necessitates careful position sizing and an understanding that its performance is likely to be highly cyclical and sensitive to shifts in market sentiment towards growth stocks.
  • Given the heavy concentration in Technology and Biotechnology, investors should closely monitor sector-specific catalysts and risks, as these will be the primary drivers of the ETF's returns.